Skip to main content
. 2018 Aug 22;8:12560. doi: 10.1038/s41598-018-29685-z

Figure 1.

Figure 1

Structure-based high-throughput screening to target SERCA2a-PLB complex. (a) Schematic diagram illustrating expression vectors and structural model of GFP-SERCA2a free or bound to RFP-PLB. (b) Time-resolved fluorescence waveforms as a readout to measure FRET between GFP-SERCA2a and RFP-PLB. FRET is calculated as the change between lifetimes (exponential decay times) of donor-only and donor-acceptor samples (τD and τDA).